Clinical Research Directory
Browse clinical research sites, groups, and studies.
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Sponsor: USWM CT, LLC
Summary
This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.
Official title: Long-Term Follow-Up (LTFU) of Participants Treated With ADP Adoptive Cell Therapies
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
250
Start Date
2018-04-09
Completion Date
2032-04-01
Last Updated
2026-03-03
Healthy Volunteers
No
Conditions
Interventions
ADP adoptive cell therapy
No study drug is administered in this study. Participants who received ADP adoptive cell therapy in a previous trial will be evaluated in this trial for long-term safety and efficacy.
Locations (24)
Emory University School of Medicine
Atlanta, Georgia, United States
ADP Investigational Site
Baltimore, Maryland, United States
National Cancer Institute - Center for Cancer Research
Bethesda, Maryland, United States
University of Michigan
Ann Arbor, Michigan, United States
Washington University School of Medicine in St. Louis
St Louis, Missouri, United States
Memorial Sloan Kettering Cancer Center - New York
New York, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
Oregon Health and Science University
Portland, Oregon, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Froedtert Hospital
Milwaukee, Wisconsin, United States
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Hôpital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Klinikum rechts der Isar der Technischen Universität München
Munich, Bavaria, Germany
Uniklinik Köln
Cologne, North Rhine-Westphalia, Germany
Fondazione IRCCS - Istituto Nazionale dei Tumori
Milan, Lombardy, Italy
Antoni Van Leeuwenhoek Ziekenhuis
Amsterdam, Netherlands
Hospital Universitario Virgen del Rocío
Seville, Spain
University College London Hospitals NHS Foundation Trust
London, United Kingdom
USWM CT Investigational Site
Manchester, United Kingdom
The Royal Marsden NHS Foundation Trust
Sutton, United Kingdom